Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Metal-Ligand Bonds02:51

Metal-Ligand Bonds

20.6K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.6K
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

484
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
484
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

433
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
433

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Robust Dynamic 3D Liver Spheroid Platform for (Sub)Chronic Toxicity Assessment: Metabolic Characterization of HepG2 Spheroids as a Case Study.

Toxicology·2026
Same author

Controlling Chemical Dynamics of Molecular Assemblies through Nanoconfinement: <i>o</i>-Nitrosocumene@Pd Nanocage.

The Journal of organic chemistry·2026
Same author

Evaluation of the Pharmaceutical Equivalence of Lidocaine and Prilocaine Creams.

Pharmaceutics·2026
Same author

Link between Spin-Orbit Relativity and Magnetically Induced Current Densities in Heavy-Atom Hydrides: <i>trans</i>-Ligand Influence.

JACS Au·2026
Same author

Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights.

European journal of medicinal chemistry·2026
Same author

Triphenylene chromophore enhances emission in Au/Cu heterometallic complexes.

Dalton transactions (Cambridge, England : 2003)·2026

相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

876

基于环氧的金属有机框架作为生物活性的应用平台(III) 复杂的复合物.

Mahya Asgharian Marzabad1,2,3, Sára Kollárová1, Fangfang Pan4

  • 1Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 62500 Brno, Czechia.

Inorganic chemistry
|May 23, 2025
PubMed
概括

(III) 复合物显示出抗癌潜力,但面临的交付挑战. 将这些金属药物封装在基于环氧的金属有机框架 (CD-MOF-1) 中,可提高疗效并降低毒性,从而改善癌症治疗.

更多相关视频

HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin
11:15

HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin

Published on: July 23, 2016

10.2K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

3.5K

相关实验视频

Last Updated: Jun 14, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

876
HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin
11:15

HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin

Published on: July 23, 2016

10.2K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

3.5K

科学领域:

  • 材料科学 材料科学 材料科学
  • 纳米技术纳米技术
  • 在瘤学瘤学.

背景情况:

  • (III) 复合物具有抗癌性质,毒性低于药物.
  • 挑战包括不良的溶解性,稳定性和 (III) 复合物的非特异性传递.
  • 金属有机框架 (MOFs) 被探索为传递系统,以提高金属药物疗效.

研究的目的:

  • 为了研究一个 (III) 复合物 (RuC) 融入γ-环极 (γ-CD) 衍生MOFs (CD-MOF-1).
  • 评估RuC-CD-MOF-1药物输送系统的*体外*抗癌疗效和细胞毒性.
  • 评估RuC-CD-MOF-1作为金属药物输送平台的潜力.

主要方法:

  • 使用γ-环氧和离子合成CD-MOF-1.
  • 在CD-MOF-1结构中封装一个生物活性 (III) 复合物 (RuC).
  • 使用HepG2肝母细胞瘤细胞球体进行体外活力研究,以评估细胞毒性和疗效.

主要成果:

  • RuC-CD-MOF-1系统证明有效地抑制了癌细胞的活力.
  • 在10天内,观察到从MOF中缓慢,逐渐释放RuC.
  • 与裸体RuC相比,封装RuC显著降低了急性细胞毒性作用.

结论:

  • RuC-CD-MOF-1作为金属药物的有效药物输送平台.
  • 该系统通过提供持续释放和减少宿主毒性来提高治疗疗效.
  • 这种方法对开发优化金属药物基础的癌症疗法充满希望.